RESUMO
Since 2008 Cardiological Dispensary of Khanty-Mansi Autonomous Okrug "Center of Diagnostics and Cardiovascular Surgery" has been participating in Rossiysky Registry of Acute Coronary Syndrome. In this paper we present some of the results on the use of percutaneous coronary interventions, time intervals, characterizing urgent medical aid to patients with acute coronary syndrome, rate of complications, and mortality.
Assuntos
Síndrome Coronariana Aguda , Intervenção Coronária Percutânea , Complicações Pós-Operatórias/epidemiologia , Síndrome Coronariana Aguda/diagnóstico , Síndrome Coronariana Aguda/mortalidade , Síndrome Coronariana Aguda/cirurgia , Eletrocardiografia , Feminino , Mortalidade Hospitalar , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação de Processos e Resultados em Cuidados de Saúde , Intervenção Coronária Percutânea/efeitos adversos , Intervenção Coronária Percutânea/métodos , Sistema de Registros/estatística & dados numéricos , Medição de Risco , Fatores de Risco , Federação Russa/epidemiologia , Taxa de Sobrevida , Tempo para o Tratamento/estatística & dados numéricos , Resultado do TratamentoRESUMO
AIM: To analyze the individual indicators of emergency medical care in ST-segment elevation (STSE) acute coronary syndrome (ACS) according to the data of the ACS Register of the District Cardiology Dispensary, Center for Diagnosis and Cardiovascular Surgery, Khanty-Mansi Autonomic District-Yugra, Surgut, over time from 2008-2010 and 2011 versus the data of health care facilities taking part in the ACS Register. MATERIALS AND METHODS: The quality of medical care for patients with STSE ACS was considered and analyzed in accordance with "The information analytical system user's guide for the integrated rapid assessment of the quality and level of organization of medical care for patients with acute coronary syndrome to "The Federal Register of Patients with ACS". RESULTS: The data of the ACS Register of the Surgut District Cardiology Dispensary indicate that the majority of patients with STSE ACS are males (86.9%); the patients' median age is 56.0 (range 51.0-61.0) years. The scope of performed drug therapy is comparable with the data of the European Registers: aspirin (97.6%), clopidogrel (93.7%), anticoagulants (98.5%), angiotensin-converting enzyme inhibitors (96.6%), beta-blockers (96.1%), and statins (87.4%). In STSE ACS, percutaneous coronary intervention is performed in 93.7% of cases; thrombolytic therapy in 14.6%; emergency coronary bypass surgery in more than 3%. CONCLUSION: The individual indicators characterizing the level of medical care for STSE ACS were analyzed using the ACS Register.
